NCT07185139View on ClinicalTrials.gov

MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

September 12, 2025

Primary Completion Date

August 30, 2026

Study Completion Date

September 30, 2026

Conditions

Sjögren's Syndrome

Interventions

DRUG

MSCohi-O Lenses

Each subject will wear MSCohi-O Lenses for 12 hours a day, totally 14 wearings.

All Listed Sponsors

lead

Guangdong ProCapZoom Biosciences Co., Ltd.

INDUSTRY